Orgenesis Inc.
Cell populations, methods of transdifferentiation and methods of use thereof
Last updated:
Abstract:
The present invention provides methods for the sequential and temporally-regulated administration of pancreatic transcription factors to induce non-pancreatic cells to transdifferentiate and mature along the pancreatic .beta.-cell lineage. The present invention also provides methods for identifying, isolating and enriching transdifferentiation predisposed cells and methods for treating a degenerative pancreatic disorder such as diabetes.
Status:
Grant
Type:
Utility
Filling date:
25 Apr 2018
Issue date:
16 Mar 2021